LOS ANGELES, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MacroGenics, Inc. (“MacroGenics” or “the Company”) (NASDAQ: MGNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between March 7, 2024 and May 9, 2024, inclusive (the “Class Period”) ...